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The risk assessment of GM stacked events, which are consid-
ered as a new GMO in the EU, could be less extensive than
the assessment of the parental GM events. This will be the
case when the latter have been proven to be safe for the hu-
man health and the environment for the same uses as the
GM stacked event. Criteria for the risk assessment of GM
stacked events combining positively assessed GM parental
lines are proposed. Molecular and comparative analysis data
are put forward as minimum requirements. Additional food/
feed safety testing and environmental studies are considered
relevant on a case-by-case basis.
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The commercial introduction of genetically modified
(GM) crops is no longer a hypothetical fact in the European
Union (EU). Since the lifting of the de facto moratorium in
2004, a number of new GM events have been authorised for
food, feed, import and/or processing. Moreover, the cultiva-
tion of GM maize is gradually increasing as a result of the
inscription of various transgenic maize varieties in the com-
mon EU catalogue of varieties of agricultural plant species
(for review see Devos, Reheul, & De Schrijver, 2005). Until
recently, the dossiers handed in for market authorisation
solely covered single GM events. Nowadays, there is a clear
trend to combine two or more transgenic traits present in
single events through traditional breeding. This is in partic-
ular the case for maize events due to the hybrid tradition in
the crop (Table 1). The obtained plants are referred to as
GM stacked events.
According to current regulatory practice within the EU,
stacked events are considered as newGMOs: prior tomarket-
ing they need regulatory approval, including an assessment
of their safety, similar to single events. In other nations,
like theUnited States, thismay not be obligatory (e.g.Kuiper,
Kleter, Noteborn, & Kok, 2001). An interesting example of
the regulatory requirements for assessment of a GM stacked
event derived from previously assessed single events is
MON810MON863 maize fromMonsanto, which was ap-
proved under Directive 2001/18/EC for commercialisation
on 13 January 2006 (EC, 2006). In the procedure leading to
the positive opinion on MON810MON863, the Scientific
Panel of the European Food Safety Authority (EFSA) in-
volved in the evaluation of genetically modified organisms
(GMOs) requested confirmatory data next to the various
data that it had already received on this stacked event. The ad-
ditional data consisted of a 90-day rat toxicity feeding study
in order to finalise the assessment (EFSA, 2005a). Interest-
ingly, upon publication of the EFSA opinion on MON810
MON863, the British Advisory Committee on Release to the
Environment (ACRE) issued a contrasting statement that no
additional information is needed for the risk assessment of
GM stacked events. This Committee considered that the con-
firmation of the safety profile of the two parent lines is suffi-
cient to support a positive assessment of a GM stacked event
that has been produced by conventional breeding (ACRE,
2004). The risk assessment of GM stacked events has been
put on the agenda of several (inter)national fora (e.g.
EFSA, 2006a; FAO/WHO, 2006; FIFRA, 2004). This gives
102 A. De Schrijver et al. / Trends in Food Science & Technology 18 (2007) 101e109Table 1. Overview of positively assessed or notified single and stacked GM cotton, maize and oilseed rape events in the EU (August 2006)
Cotton
Notified stacked
cotton events
Commercial uses Single cotton events Approved or positively
assessed commercial uses
MON531MON1445 FO, FE MON531 FO-
MON1445 FO-
MON15985, MON15985MON1445 FO, FE MON15985 d
MON1445 d
281-24-236 3006-210-23 FO, FE 281-24-236 d
3006-210-23 d
LLcotton25MON15985 FO, FE LLcotton25 d
MON15985 d
Maize
Positively assessed
stacked maize events
Commercial uses Single maize events Approved or positively
assessed commercial uses
MON863MON810 FO, FE MON863 FO, FE, IM, IP
MON810 FO-, FE, IM, IP, CU
MON863NK603 FO, FE, IM, IP MON863 FO, FE, IM, IP
NK603 FO, FE, IM, IP
MON863MON810NK603 FO, FE, IM, IP MON863 FO, FE, IM, IP
MON810 FO-, FE, IM, IP, CU
NK603 FO, FE, IM, IP
MON863MON810 IM, IP
NK603MON810 FO, FE, IM, IP NK603 FO, FE, IM, IP
MON810 FO-, FE, IM, IP, CU
1507NK603 FO, FE, IM, IP 1507 FO, FE, IM, IP, CUa
NK603 FO, FE, IM, IP
Notified stacked
maize events
Commercial uses Single maize events Approved or positively
assessed commercial uses
1507 59122 FO, FE, IM, IP, CU 1507 FO, FE, IM, IP, CUa
59122 d
1507NK603 CU 1507 FO, FE, IM, IP, CUa
NK603 FO, FE, IM, IP
1507NK603 FOa, FEa, IMa, IPa
NK603MON810 CU NK603 FO, FE, IM, IP
MON810 FO-, FE, IM, IP, CU
NK603MON810 FOa, FEa, IMa, IPa
1507 59122 FO, FE, IM, IP, CU 1507 FO, FE, IM, IP, CUa
DAS-59122-7 d
DAS-59122-7NK603 FO, FE, IM, IP, CU DAS-59122-7 d
NK603 FO, FE, IM, IP
DAS-59122-7 1507NK603 FO, FE, IM, IP, CU DAS-59122-7 d
1507 FO, FE, IM, IP, CUa
NK603 FO, FE, IM, IP
LY038MON810 FO, FE, IM, IP LY038 d
MON810 FO-, FE, IM, IP, CU
MON88017MON810 FO, FE, IM, IP MON88017 d
MON810 FO-, FE, IM, IP, CU
Oilseed rape
Positively assessed
stacked oilseed rape events
Commercial uses Single oilseed
rape events
Approved or positively
assessed commercial uses
MS1, RF1, MS1 RF1 FO-, CU MS1 FO-, CU
RF1 FO-, CU
MS8, RF3, MS8 RF3 FO-, IM, IP MS8 FO-, IM, IP
RF3 FO-, IM, IP
Belgian Biosafety Server: http://www.biosafety.be; European Commission: http://europa.eu.int/comm/food/food/biotechnology/index_en.htm;
European Food Safety Authority: http://www.efsa.europa.eu
Abbreviations: FO¼ food (all products); FO-¼ food (only derivatives); FE¼ feed; IM¼ import; IP¼ industrial processing; CU¼ cultivation.
a Positively assessed events by EFSA.
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assessment of GM crops for food, feed and environmental
applications is rigorous, it would merit from harmonisation
of the requirements for stacked events.
Information on how GM stacked events should be
assessed is rare. Only the industry platform, EuropaBio
has published a document on the evaluation of GM stacked
events (EuropaBio, 2005) formulating some guidelines for
risk assessment. Scientific argumentation as to why infor-
mation is asked for risk assessment is even scarcer. The ob-
jective of this paper is (1) to review and discuss the risk
assessment of environmental, animal and human safety as-
pects related to stacks obtained from the crossing of GMOs
and (2) to provide some guidance on how risk assessment
of GM stacked events might be performed. Gaps in knowl-
edge are identified.
Defining GM stacked events
Often reference is made to ‘stacked products’, ‘stacked
events’, ‘breeding stacks’, ‘stacked genes’ or ‘pyramided
traits’, when talking about GM crops obtained through con-
ventional cross breeding. In the OECD guidance document
on the designation of a unique identifier for transgenic
plants (OECD, 2002), stacked transformation events are de-
fined as new products with more than one transformation
event. For the purpose of this paper, the OECD definition
remains too broad. According to the logic of the OECD
definition, a stacked transformation event could be a
re-transformation of an existing transgenic line or a cross
between two GM transgenic lines (for more information
on how to obtain stacks see Halpin, 2005). As the risk
assessment of re-transformed events will follow the sce-
nario of a single GM event, these do not fall under the
events considered in the current paper. Here, solely plants
obtained from crosses of GM events are considered when
speaking of GM stacked events.
Also the terms GM hybrids and GM stacked events
should not be confused. In case of GM hybrids, the trans-
genic trait originates from the GM inbred parental line
that was crossed with one (or more) non-transgenic elite
inbred line(s). In case of GM stacked events two or more
transgenic traits are brought together by crossing GM in-
bred lines each transformed with different events (Fig. 1).
One-way GM stacked events, where two transgenic traits
are combined, and three-way GM stacked events, where
three transgenic traits are combined, have been notified
for authorisation in the EU (Table 1). GM stacked events
combining more than three transgenic traits can be ex-
pected. GM hybrid lines derived from an approved GM
event are covered within the scope of EU market consents
implicating that their safety has been assessed.
Risk assessment of GM stacked events
Though GM stacked events should be evaluated in the
EU for their risks for the environment and animal/humanhealth, the question remains how this should be done and
which data are needed. When discussing this topic, one
should keep in mind that for any GMO to be deliberately
released in the environment, according to EU legislation,
the risk assessment should include information on environ-
mental aspects (EC, 2001). In case the GM crop will be
used for animal (feed) or human nutrition (food), the risk
assessment should contain additional information on toxi-
cological, allergenic and nutritional food/feed aspects
(EC, 2003a).
When taking a closer look at the dossiers notified under
the EU GMO legislation, one can classify the GM stacked
events into two different subgroups each posing their
specific risk assessment challenges (Table 1). One group
of GM stacks comprising GM events that have already
been proven to be safe for the same uses as the GM
stacked event, a second group of which at least one GM
event has not been proven to be safe for the same use as
the GM stack. A GM event is considered to be safe in
case an authorisation for marketing in the EU has been
granted or in case a favourable scientific EFSA opinion
has been published (for risk assessment criteria see
EFSA, 2004).
The risk assessment of GM stacked events combining
positively assessed single GM events could logically start
from the risk assessment performed on the GM parental
lines. However, proof might be needed in order to be able
to extrapolate the risk assessment studies done on the
parental GMOs to the GM stacked event.
Fig. 1. Successive steps in the development of GM hybrids and GM
stacked events.
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assessed single GM maize events and a GM oilseed rape
stacked event have already been evaluated for their risks
for the environment and human/animal health in the EU
(EFSA, 2005a, 2005b, 2005c, 2005d, 2005e, 2005f,
2005g, 2006b). In the scientific risk evaluations carried
out by the EFSA, assessment data for the single GM events
were taken into account, besides the data provided by the
notifier for the evaluation of the GM stacked events. All
dossiers contained genotypic data, usually a Southern
blot, to demonstrate that the molecular structures of the
DNA inserts of the GM stacked events were unchanged
and data on the expression levels of the traits in the GM
stacked events. Comparative data, including agronomic
performance, compositional analysis and wholesomeness
studies using broiler chickens or rabbits were provided
for the GM stacked events. A 90-day rat toxicity study
was provided or requested, except for MS8RF3
(EFSA, 2005e), NK603MON810 (EFSA, 2005f) and
1507NK603 (EFSA, 2006b), to assess the whole
food/feed toxicology of the GM stacked event. In those
three particular cases, it was concluded that the informa-
tion already provided for the assessment of the GM
stacked event was sufficient to prove the safety of the
whole food/feed. No additional information was consid-
ered necessary for the evaluation of possible increased
allergenicity of the whole GM stacked crops, since neither
maize nor oilseed rape is considered as a common allergic
food.
In the present paper, it is explored which studies per-
formed on the GM parental lines could remain valid for
the evaluation of a GM stacked event and what type of in-
formation is needed to extrapolate the risk assessment data
of the parental GM lines to the GM stacked event. Also
whether additional information is needed to allow a thor-
ough risk assessment of the GM stacked event is discussed.
We have tried to develop a GM stack holistic risk assess-
ment approach starting from the identification of the molec-
ular data of the GM stacked event required to evaluate
various safety aspects. As a case study, a GM stack ob-
tained by the crossing of two GM events is taken. Obvi-
ously, the same reasoning is applicable for the evaluation
of three-way GM stacked events or GM stacked events
combining more than three transgenic traits. Every safety
evaluation aspect, including environmental and food/feed
aspects needed to prove the biosafety of the GMO will be
discussed in detail.
Molecular characterisation
When commencing a risk assessment of a GM crop,
one needs to be certain that the event under evaluation
contains the desired characteristics. Therefore, for single
GM events, data are provided on the actually inserted se-
quences. Merely as a means of confirmation of the pres-
ence of the transgenic characteristics in the GM stacked
event, their inheritance should be documented. Takeninto consideration that for all authorised single GM
events, Southern blot analyses are used to prove correct
transfer to different genetic backgrounds by conventional
breeding, this type of genotypic analysis could provide
the necessary basic molecular information on the GM
stacked event.
In the following chapters on risk assessment issues, it is
documented that besides the presence of the trait(s), it is
also relevant to demonstrate the maintenance of the re-
gions flanking the insert, since this will allow extrapolation
of the bio-informatic analysis carried out on the junction
regions of the single GM events. Bio-informatic analyses
are conducted to identify potential chimaeric open reading
frames (ORFs) in the junction regions of the insert. Given
this, one can consider to not only confirm the maintenance
of the transgenic traits of the GM stacked event via South-
ern blot analysis, but also of the regions flanking the
inserts.
Southern blot analysis of the GM stacked event can
confirm the maintenance of the transgenic inserts of the
GM parental lines, comprising their copy number and
structure. It will, however, only confirm the gross structure
of the inserts; point mutations, small deletions and rear-
rangements that might occur during breeding will not be
detected. Only via sequencing these can be visualised.
Several issues should be taken into account when consid-
ering if sequence information is needed for the evaluation
of GM stacked events. There is a common saying that
transgenic DNA inserts (including the flanking regions) re-
main unchanged during breeding. However, hardly any, if
none, scientific evidence proving that (trans)genes are in-
herited in an intact way during breeding is publicly avail-
able. In particular, information on the occurrence of point
mutations, deletions and/or rearrangements during breed-
ing is lacking. Only in case of the Bt11 event, it has
been proven at sequence level that no genetic rearrange-
ment or deletion in insert or flanking regions has occurred
when crossing the inbred Bt11 field maize with an elite
sweet maize cultivar (BAC, 2004). On the other hand,
there is also no scientific argument to say that transgene
inserts would behave differently than endogenous se-
quences in function of mutation rate. Given the absence
of scientific proof, one can question the need or necessity
of asking sequence data. However, the question of impor-
tance for biosafety assessment is whether structural modi-
fications of the insert not detected through Southern blot
and that might occur during traditional breeding will im-
pose any risk. For example, a rearrangement might lead
to the formation of a new ORF; a deletion, might result
in an inactive protein; a point mutation might influence
the characteristics of the expressed protein. The true im-
pact of ‘small’ insertional changes on the intrinsic charac-
teristics of the crop will, however, not be completely
resolved through sequence analysis followed by bio-infor-
matic analysis (e.g. small deletions of a gene might still
result in an active protein). As expression levels of the
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evaluation of the whole food/feed, will reveal more on
the impact of potential ‘small’ molecular changes that
might occur during interbreeding of GM events than se-
quence analysis, the latter might be considered irrelevant
to ask.
A second identified requirement for data extrapolation is
the knowledge of the transgene expression levels in the
GM stacked event. Transgene expression may change
when a transgene is placed in a different genetic back-
ground through breeding. In addition, one should take
into consideration that in the case of GM stacked events,
the combined presence of transgenes might influence
expression. For example, gene silencing that involves
transgene/transgene interactions might occur in case ho-
mologous DNA sequences, e.g. expression controlling
elements, are brought together (Fagard & Vaucheret,
2000). Therefore, it will be relevant to determine if trans-
gene expression has changed in the GM stacked event
compared to the single event.
An additional molecular aspect that is considered in
the evaluation of GM crops, is the stability of the inserts
over several generations. However, when determining
whether this information is needed, one should take
into consideration that during breeding only hybrids
with stable inserts are retained to produce hybrid-sowing
seed. In addition, as the hybrid crop (F1) or grains pro-
duced on the hybrid crop (F2) will be harvested and pro-
cessed, information on the stability of the insert will not
necessarily add to the risk safety assessment of the GM
stacked event. Only if part of the F2 progeny will be
used for cultivation or the GM stack will be used for
GM hybrid maize production, data on the stability of
the insert over several generations will be relevant, given
the prolonged environmental exposure. The use of F2
seed is, however, not a common agricultural practice in
the EU.
Comparative analysis
An important issue to be evaluated, is whether the
agronomic and morphological characteristics, and compo-
sition of the GM stacked event remain the same compared
to the traditionally grown crop or the single GM events.
Comparative analysis might identify unintended effects
resulting from the interbreeding of GM varieties (e.g.
synergistic or antagonistic interactions of the transgenic
proteins). If statistically significant differences are found
with the comparator, the impact of these changes should
be further assessed to determine their biological
significance.
Agronomic, phenotypic and compositional data are
generally collected from field trials carried out in a range
of agricultural environments that are typical of the place
where the crop is grown. Agronomic performance studies
include evaluations of plant vigour, growth habit, yield,
crop quality, and insect and disease susceptibility.EuropaBio considers data collected from four sites over
a single growing season sufficient to allow a thorough anal-
ysis (EuropaBio, 2005). Commonly, the non-GM equi-
valent is used as the appropriate comparator in the
comparative analysis studies given that the genetic back-
ground is comparable (EFSA, 2004). In the case of GM
stacked events, however, the single event might also serve
as a good comparator.
Environmental aspects
The environmental risk assessment of a GM crop is
based on the recipient, the genetic modification, the
GMO, the intended release or use, the potential receiving
environment and the interaction between these (EC,
2002). The environmental risk assessment data on the
recipient, the genetic modification and the potential receiv-
ing environment of the single GM events will remain valid
for the GM stacked event. Since the GM stacked event is
considered as a new GMO, aspects linked to the GM
crop that might alter its interactions with the environment
will be relevant to take into consideration during risk
assessment.
A change in the level of expression of the introduced
proteins in the GM stacked event compared to the GM
parental line might on a case-by-case basis affect the
agro-ecosystem. Higher levels of transgene expression
might result in unintended adverse effects on non-target
organisms; lower levels might lead to increased risk for
insect-resistance of target organisms. If it has been shown
on the basis of the molecular studies that the level of
expression of the single GM event corresponds to that of
the GM stacked event, data proving the environmental
safety of the single GM event can be passed on to the
GM stacked event. In case the expression level of an
introduced/modified trait in the GM stacked event falls
outside the range of the one determined in the GM parental
line, a re-evaluation of the environmental aspects might
be necessary, if considered relevant (depending on the
trait). It must be noted that whether an assessment of the
environmental aspects is needed or not, will not only
depend on the transgenic trait considered, but also on the
intended release or use of the GM stacked event. Only in
this case the GM stacked event is released for cultivation,
data on the expression level of the new proteins will be needed
in order to determine if the effect of the GM crop on the
environment will remain the same compared to the single
GM events.
In GM stacked events, several traits e currently limited
to insect and herbicide resistance in the EU applications e
are brought together. Special attention should be given to
GM stacks that combine events with transgene protein
products that have a similar and potentially synergetic
type of mode of action. The combined presence of two
toxins might result in a changed effect on target and non-
target organisms, or lead to cross-resistance. Unless there
is an indication that proteins would interact, such as being
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there is little to justify testing the combined effect of the
toxins. The notified stacked events that need attention for
the moment are those combining Bacillus thuringiensis
(Bt) toxins. Bt insecticidal proteins are toxic due to their
action as pore formers in insect gut mediated through spe-
cific binding to membrane proteins. As different Bt toxins
share specific binding sites (Estela, Escriche, & Ferre,
2004; Hua, Masson, Jurat-Fuentes, Schwab, & Adang,
2001; Li et al., 2004; Schnepf et al., 1998), synergetic
(non-)target effects and cross-resistance mediated by
changes in receptors can be envisaged.
The presence of multiple resistance traits can also pro-
vide a selective advantage (Snow et al., 2003), by which
the persistence and invasiveness of the crop or sexually
compatible relatives could be enhanced (Chapman &
Burke, 2006). Moreover, multiple resistance traits in com-
bination with novel agricultural practices might lead to
changes in farmland biodiversity (Ammann, 2005).
In case of cultivation and depending on the crop and
traits, on the one hand, field experimentation with the
GM stacked event might be considered before commerci-
alisation. On the other hand, post-market monitoring
could be envisaged to study the potential adverse agro-
ecological effects of the cultivation of GM stacked
events.
Toxicology and allergenicity testing: protein safety
evaluation
When testing newly expressed proteins e be it the in-
tended traits or the unintendedly expressed proteins e of
a GM crop for their toxicology and allergenicity aspects,
it is recommended, as a first step in the assessment to con-
duct bio-informatic analyses on the inserted transgenic
DNA. This will allow comparison of the transgenic pro-
tein(s) with those of allergenic and toxic proteins (EFSA,
2004). If correctly conducted, bio-informatic analyses
will give a first indication of the toxic and allergenic poten-
tial of the proteins expressed by the inserted transgenic
DNA. Consequently, in vitro tests investigating the biolog-
ical toxic potential and the potential of the newly expressed
proteins to elicit allergic reactions more into detail are car-
ried out. By feeding purified proteins to test animals, the
toxicology potential of the newly expressed proteins is of-
ten further evaluated in vivo.
When considering which toxicity and allergenicity stud-
ies done on the single GM events remain valid for the GM
stacked event and in particular the conditions under which
they remain valid, one falls back on the molecular charac-
terisation studies. If during crossing, the insert and the
flanking regions of the GM parental events are transmitted
intactly to the GM stacked event, the bio-informatic analy-
ses done on the GM parental inbred lines to identify the
toxic and/or allergenic potential of any newly produced
protein will remain valid for the GM stacked event.Obviously, also the in vitro investigations and the oral tox-
icity studies done with purified target proteins will remain
valid for the GM stacked event. In other words, if it has
been demonstrated that the inserts and junction regions
are maintained and that the introduced traits or newly ex-
pressed chimaeric proteins present in the single events
will not act as allergens or toxins in the GM parental inbred
lines, it is not relevant to demonstrate this again in the GM
stacked event.
Toxicology and allergenicity testing: testing of whole
GM food/feed or crop
Risk assessment of the whole GM plant must consider
whether allergenicity or toxicity of the crop could be in-
creased. This is particularly important when the non-GM
host plant is known as an allergen or toxin source. Toxicity
testing most often includes a 90-day toxicity study in
rodents; allergenicity testing is done by comparison of the
allergen repertoire of the GM crop with that of the conven-
tional non-GM variety.
When considering the extrapolation of whole GM food/
feed toxicology studies, one should take into account that in
the GM stacked event the expression level of the introduced
traits might be different from that of the GM parental lines.
One can postulate that an increase in the amount of newly
expressed protein could lead to a toxic effect if the protein
is potentially toxic. The level of expression of the newly in-
troduced trait in the GM stacked event will, however, have
to be compared to the levels at which this protein exerts
toxic effects in toxicity tests, i.e. the so-called margin of
safety (MoS). If the MoS is large for the GM parental
line, it can be envisioned that the expression in the stacked
event needs to be much higher than the level of expression
determined in the GM parental inbred line to cause a toxic
effect. In summary, one can say that the information on the
expression level of the newly introduced traits in the GM
stacked event is relevant with regard to the possible need
for whole GM food/feed toxicology studies of the GM
stacked event. However, it should be realised that such
whole food testing experiments have their limitations, due
to limited dose range and complexity of the product (e.g.
Kuiper et al., 2001).
Another aspect that is of concern when considering the
extrapolation of the whole GM crop or food/feed toxicol-
ogy and allergenicity studies carried out with single GM
events to the GM stacked event, are the potential interac-
tions of the newly introduced genes, regulatory sequences
and proteins (or its metabolites) with the host genome of
the GM stacked event. Given that the transgenic DNA
sequences/proteins are brought into a different genetic
background, namely the stacked genetic background, their
interaction with the genome might change, particularly if
regulatory proteins, such as in experimental stress-resistant
crops described in literature, are involved. Interactions
with the genome might lead to a change in overall toxicity
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plant is known to be allergenic or toxic in its own right.
One should take into account that there are no tests avail-
able to predict if interactions of the newly introduced
DNA sequences/proteins at cellular level will occur. Indi-
rect evidence has to be obtained from extensive analysis of
compositional, phenotypic and agronomic characteristics.
Whether the natural amount of toxins has changed, can
be revealed by compositional analysis. If uncertainty re-
mains or if differences are indeed confirmed, overall tox-
icity testing of the GM stacked event may be
considered. As discussed above, animal toxicity testing
with whole food has its limitations, for example with re-
gard to sensitivity, and may not be able to pick up subtle
differences that are detected by compositional analysis
(e.g. Chassy et al., 2004; Kuiper et al., 2001). Whether
the natural amount of allergens has been changed can be
revealed by comparing the allergen repertoire between
the non-GM and the GM stacked event. Although, differ-
ent in vitro methods are available for that purpose, some
of them using patients’ sera, they are not all well-validated
methods.
Last but not least, toxins individually considered safe
might lead to unacceptable health effects when exposure
is to a combination. Only in case synergistic toxic effects
are expected (e.g. toxins with common health effect), it
will be relevant to demand additional toxicity studies, the
exact nature of which will depend on the data available
and the characteristics of the modified crops, transgenes,
and anticipated effects.
Nutritional food/feed assessment
In the evaluation of the nutritional aspects of a single GM
event, the raw agricultural commodities and, on a case-by-
case basis, the processed fractions, are assessed for key
nutrients as well as naturally occurring anti-nutrients, toxi-
cants and secondary plant metabolites (EFSA, 2004).
Once compositional equivalence, except for the introduced
traits, has been established between a GM food or feed
with its conventional counterpart, nutritional equivalence
can be assumed (Clark & Ipharraguerre, 2001). Further
nutritional analysis, including animal performance, feed
and digestion studies could be done; however, such studies
should be considered on a case-by-case basis (Kuiper
et al., 2001).
Compositional analyses carried out on parental GM
events combined in a stack cannot be extrapolated per se
to the stacked event. Through hybrid breeding the compo-
sition of a crop might change. Interactions of transgenes
and the newly expressed proteins might result in effects
on biochemical pathways (Pinc¸on et al., 2001). Therefore,
compositional analysis of the GM stacked event is relevant
for risk assessment to identify if any possible adverse ef-
fects might result from a change in composition. Animal
feeding trials are an additional tool to establish nutritionalequivalence and to test the nutritional properties of the
GM stacked event product.
Conclusions
In this article the risk assessment of GM stacked events,
defined as plants obtained from the crossing of GM events,
is discussed in order to provide some guidance for their as-
sessment. Whether data are needed at all for risk assess-
ment of GM stacked events, has been argued by ACRE
(ACRE, 2004). Objections to accept certain criteria for
the risk assessment of GM stacked events might be the re-
sult of the fact that no legislation at European level depicts
that non-GM hybrids should be tested for their safety for
the environment and human/animal health. If non-GM hy-
brids need no testing, why should this then be done for
GM stacked events? In addition, the fact that from a legal
point of view it remains vague whether GM stacked events
should be evaluated, could add to the restraint to ask for
safety assessment data. Nowhere in EU legislation is it
clearly stated that a hybrid obtained through the crossing
of two GMOs is considered as a new GMO and therefore
should be evaluated for its risks for the environment and
human/animal health. This vagueness can lead to individual
interpretations of the legislation. However, as the European
Commission considers a GM stacked event as a new GMO
(EC, personal communication), risk assessment data should
be provided as part of the approval process (EC, 2003b;
EFSA, 2004).
When reflecting on the risk assessments of GM stacked
events, it becomes clear that these could be less exhaustive
compared to the risk assessments of single GM events when
the GM parental lines have already been positively assessed
for their biosafety. In the present paper, it is shown that the
safety assessments of the parental GM events form a good
basis for the evaluation of GM stacked events taking into
account that all uses of the GM stacked event under evalu-
ation are covered in the assessed parental GM lines. How-
ever, additional information proving the validity of the
studies carried out on the GM parental lines for the GM
stacked event will be needed to complete the risk assess-
ment together with data proving the biosafety of the GM
stacked event. In case one or more GM parental lines
have not been evaluated under EU legislation, one can
choose to carry out a complete risk assessment on the
non-assessed GM parental line(s) or on the GM stacked
event. The risk assessment of the GM stack should, how-
ever, also include an evaluation of single events as the off-
spring, which are segregating plants, will be used for
consumption.
Minimum requirements identified in order to be able to
extrapolate data obtained with the parental GM lines to
the GM stacked event are: (1) evidence of the presence
and the copy number of the parental inserts (including
the flanking regions) in the GM stacked event and
(2) evidence that the levels of expression of the newly
108 A. De Schrijver et al. / Trends in Food Science & Technology 18 (2007) 101e109expressed proteins in the GM stack equal to that of the
GM parental lines. Proof that the insert is conserved dur-
ing the breeding process, is needed to consider the studies
on protein and food/feed safety conducted on the GM
parental lines as valid for the risk evaluation of the GM
stacked event. Solely if the insert is conserved in the
GM stacked event, and consequently also the characteris-
tics of the transgenic protein, studies done to test the
safety of the new proteins in the single GM events will
also apply for the stack. Logically, food/feed safety data
linked to the insert will only apply both for the single
GM and the stacked event in the case of molecular equiv-
alence at insert and protein level. In case of cultivation,
and depending on the traits considered, information on ex-
pression level is also needed to be able to extrapolate en-
vironmental biosafety studies carried out with the parental
GM lines to the GM stacked event.
As in GM stacked events several traits are combined, it
is recommended to at least carry out agronomic, morpho-
logical and compositional studies on the GM stacked event
in order to identify potential adverse effects that might re-
sult from interbreeding of GM cultivars. These studies will
reveal if the phenotype and the composition, including the
amount of naturally occurring allergens and toxins, of the
GM stacked event will be equivalent to its comparators.
If changes have been detected, their impact will need to
be further assessed. Further testing of the potential adverse
effects of the combined presence of traits needs to be consid-
ered on a case-by-case basis. If compounds with a synergistic
toxic potential for animals and/or humans are combined in
the GM stacked event, additional toxicity testing is con-
sidered relevant. Additional environmental studies and/or
post-market monitoring will be relevant if, for instance, there
is an increased risk of invasiveness, synergistic toxic effects
on non-target organisms or cross-resistance due to the com-
bined presence of several traits.
Several safety assessment issues touched upon in this
article in the light of the evaluation of GM stacked events
also account for single GM events. For instance, the dis-
cussion on the need of information on expression level
of traits in a new genetic background is relevant for
both single and stacked GM events. In the evaluation of
dossiers for the placing of a single GM event on the mar-
ket, hybrid lines obtained from crosses of a GM line with
one or more conventional bred inbred lines are assessed.
Via Southern blot analysis it is assessed if the insert re-
mains stable in different genetic backgrounds. Environ-
mental risk assessment studies and food/feed safety
assessment studies are conducted on the hybrids to be
placed on the market. Therefore, one can say that the
evaluation of GM stacked events is different from the
assessment of GM hybrids in respect that the combined
effects of the transgenes and the effects of the potential
interactions between the newly expressed proteins should
be assessed.Acknowledgements
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